Search results
Here, the president of CHCAMS, and NCC director, Jie He, discusses CHCAMS’s role in standardizing China’s cancer clinical trials. Credit: Cancer Hospital, Chinese Academy of Medical...
Jie He's 130 research works with 21,226 citations and 19,796 reads, including: Prediction of Tumor Microenvironment Characteristics and Treatment Response in Lung Squamous Cell Carcinoma by...
Jie He. Author information. Current affiliation: Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Scopus ID: 57209705058. 33,364. Citations from 30,265 documents. 436. Documents. 63. h -index. 3. Preprints. 1,797. Co-authors. View full profile in Scopus. Request profile edit.
Aug 24, 2019 · In 2013, he won the first place in National Science and Technology Progress Award (as No.1 holder). He serves as Chairman-elect of Chinese Society for Thoracic and Cardiovascular Surgery, Honorary Chairman of Esophagus Cancer Professional Board of Chinese Anti-cancer Association, Chairman-elect of CMDA Thoracic Surgeon Branch, and Editor-in ...
Aug 1, 2022 · The survival of esophageal cancer by subtype in China with comparison to the United States. Lan An, Rongshou Zheng, Hongmei Zeng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Li Li, Wenqiang Wei, Jie He. , First published: 01 August 2022. https://doi.org/10.1002/ijc.34232.
Aug 24, 2014 · Jie He and colleagues report exome sequencing of 113 tumor-normal pairs of esophageal squamous cell carcinoma. They highlight mutations in genes involved in cell cycle and apoptosis...
Jan 24, 2024 · Jie He. Nature Medicine 30 , 320–321 ( 2024) Cite this article. 496 Accesses. 4 Altmetric. Metrics. In 2016, there were approximately 4 million new cancer cases and 2.4 million cancer...
